All In Biotech

Drug Trial Radar · NCT04102501

A Study to Assess Efficacy, Long Term Safety and Tolerability of RT001 in Subjects With Friedreich's Ataxia

A Randomized, Double-Blind, Controlled, Phase 2/3 Study to Assess Efficacy, Long Term Safety and Tolerability of RT001 in Subjects With Friedreich's Ataxia

Last checked: Nov 19, 2026Latest source record: May 27, 2022 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

65

Actual

Start

Oct 30, 2019

Primary completion

Aug 23, 2021

Study completion Aug 23, 2021

Sponsor

Lead sponsor
Biojiva LLCIndustry
Sponsor type
Industry
First posted
Sep 25, 2019

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 12 years, up to 50 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to assess the Efficacy, Long Term Safety and Tolerability of RT001 in subjects with Friedreich's Ataxia

Conditions

  • Friedreich's Ataxia

Interventions

  • RT001Drug

    RT001 is encapsulated 9-cis, 12-cis-11,11-D2-linoleic acid ethyl ester, which is a site specific (C11) di-deutero synthetic homologue of LA ethyl ester. Each capsule contains 960 mg of RT001.

  • PlaceboDrug

    The placebo product is composed of encapsulated USP safflower oil. The placebo capsules are identical in appearance and size to RT001.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change From Baseline to 11 Months in Maximum Consumption of Oxygen (mlO2/kg/Min) Using Cardiopulmonary Exercise Testing (CPET)Time frame: 11 months

Locations

6 sites in 1 country. Site status is shown where the registry gives one.

  • Collaborative Neuroscience Network, LLC

    Long Beach, California

  • UCLA

    Los Angeles, California

  • University of Florida

    Gainesville, Florida

  • USF Ataxia Research Center

    Tampa, Florida

  • University of Iowa Stead Family Children's Hospital

    Iowa City, Iowa

  • Children's Hospital of Philadelphia

    Philadelphia, Pennsylvania

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.